Two Sigma Securities’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8K | Buy |
+23,003
| New | +$46.8K | 0.01% | 1117 |
|
|
2024
Q1 | – | Sell |
-9,038
| Closed | -$55.3K | – | 1769 |
|
|
2023
Q4 | $55.3K | Buy |
9,038
+1,503
| +20% | +$9.2K | ﹤0.01% | 1026 |
|
|
2023
Q3 | $35.2K | Sell |
7,535
-1,897
| -20% | -$8.86K | ﹤0.01% | 974 |
|
|
2023
Q2 | $50.5K | Buy |
+9,432
| New | +$50.5K | ﹤0.01% | 877 |
|
|
2023
Q1 | – | Sell |
-1,880
| Closed | -$35.2K | – | 1651 |
|
|
2022
Q4 | $35.2K | Buy |
+1,880
| New | +$35.2K | ﹤0.01% | 998 |
|
|
2022
Q3 | – | Sell |
-4,172
| Closed | -$87K | – | 1629 |
|
|
2022
Q2 | $87K | Buy |
4,172
+1,942
| +87% | +$40.5K | ﹤0.01% | 822 |
|
|
2022
Q1 | $96K | Buy |
+2,230
| New | +$96K | ﹤0.01% | 816 |
|
|
2021
Q2 | – | Sell |
-1,431
| Closed | -$159K | – | 867 |
|
|
2021
Q1 | $159K | Buy |
+1,431
| New | +$159K | 0.01% | 444 |
|